ProBioGen AG

📍 Berlin, Germany🗓 Founded 1994👥 163 employees💰 Last funded 2003
Biotechnology Research🌐 probiogen.de
Website LinkedIn
ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines. Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon. With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
1994
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in ProBioGen AG?
ProBioGen AG has 1 investor on record on gritt.io and 1 late-stage investors.
When did ProBioGen AG last raise funding?
The most recent investment in ProBioGen AG recorded on gritt.io was in 2003.
When was ProBioGen AG founded?
ProBioGen AG was founded in 1994.
What industry is ProBioGen AG in?
ProBioGen AG operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ProBioGen AG based?
ProBioGen AG is headquartered in Berlin, Germany.